BPH Global (ASX:BP8) Debt-to-Asset : 0.17 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is BPH Global Debt-to-Asset?

BPH Global's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. BPH Global's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.17 Mil. BPH Global's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was A$1.04 Mil. BPH Global's debt to asset for the quarter that ended in Dec. 2023 was 0.17.

BPH Global Debt-to-Asset Historical Data

The historical data trend for BPH Global's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BPH Global Debt-to-Asset Chart

BPH Global Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Asset

Get a 7-Day Free Trial

0.11

0.16

BPH Global Semi-Annual Data
	Dec07	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.16	0.16	-	-	0.17

Competitive Comparison of BPH Global's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BPH Global's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BPH Global's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BPH Global's Debt-to-Asset falls into.

BPH Global Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BPH Global's Debt-to-Asset for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	1.473
	=	0.00

BPH Global's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0.173)	/	1.043
	=	0.17

BPH Global (ASX:BP8) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

BPH Global Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of BPH Global's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

BPH Global (ASX:BP8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BPH Global Ltd (ASX:BP8) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000

Website

https://www.scu.com.sg

BPH Global Ltd, formerly Stemcell United Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and Greater China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.

BPH Global (ASX:BP8) Headlines

No Headlines